Home
Storia in 4 fonti
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Accumulating evidence of possible benefit warrants randomized trials, experts say
- ·
healio.com
GLP-1s show no significant link with diabetic retinopathy progression
Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1 receptor agonists and the progression of diabetic…
- ·
GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases
CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…
- ·
medpagetoday.com
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Accumulating evidence of possible benefit warrants randomized trials, experts say
- ·
nbcnews.com
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.
- ·
independent.co.uk
GLP-1 drugs may result in better outcomes for cancer patients, study claims
GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers